RAPT Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 05 Jan 24 | SellUS$20,456 | Dirk Brockstedt | Individual | 898 | US$22.78 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Individual Insiders | 668,132 | 1.91% |
| General Public | 1,999,269 | 5.73% |
| VC/PE Firms | 2,680,621 | 7.68% |
| Institutions | 29,555,454 | 84.7% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 5,235,521 | US$11.7m | 0.3% | no data | |||
| 3,108,268 | US$6.9m | 24.7% | no data | |||
| 2,680,621 | US$6.0m | 0% | 8.37% | |||
| 2,439,830 | US$5.4m | -1.31% | no data | |||
| 1,725,000 | US$3.8m | 15% | 0.53% | |||
| 1,024,061 | US$2.3m | 323% | no data | |||
| 1,022,364 | US$2.3m | -46.2% | no data | |||
| 1,015,837 | US$2.3m | 1,010% | 0.01% | |||
| 932,541 | US$2.1m | 222% | no data | |||
| 907,413 | US$2.0m | 236% | no data | |||
| 796,080 | US$1.8m | 189% | no data | |||
| 698,400 | US$1.6m | 104% | no data | |||
| 684,713 | US$1.5m | 0.81% | no data | |||
| 671,785 | US$1.5m | 1.88% | no data | |||
| 657,899 | US$1.5m | 0% | 0.17% | |||
| 612,305 | US$1.4m | 43.9% | no data | |||
| 540,270 | US$1.2m | 0% | 0.07% | |||
| 536,682 | US$1.2m | -19% | 0.05% | |||
| 500,000 | US$1.1m | 24.2% | 0.19% | |||
| 496,750 | US$1.1m | 0% | 0.05% | |||
| 492,618 | US$1.1m | 0% | no data | |||
| 467,182 | US$1.0m | 4,180% | no data | |||
| 331,876 | US$740.1k | -40.4% | no data | |||
| 315,000 | US$702.5k | 0% | 0.24% | |||
| 292,000 | US$651.2k | 0% | 0.09% |